1. Home
  2. KRYS vs CRC Comparison

KRYS vs CRC Comparison

Compare KRYS & CRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • CRC
  • Stock Information
  • Founded
  • KRYS 2015
  • CRC 2014
  • Country
  • KRYS United States
  • CRC United States
  • Employees
  • KRYS N/A
  • CRC N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • CRC Oil & Gas Production
  • Sector
  • KRYS Health Care
  • CRC Energy
  • Exchange
  • KRYS Nasdaq
  • CRC Nasdaq
  • Market Cap
  • KRYS 3.6B
  • CRC 3.2B
  • IPO Year
  • KRYS 2017
  • CRC N/A
  • Fundamental
  • Price
  • KRYS $125.96
  • CRC $44.18
  • Analyst Decision
  • KRYS Strong Buy
  • CRC Strong Buy
  • Analyst Count
  • KRYS 8
  • CRC 11
  • Target Price
  • KRYS $211.13
  • CRC $61.27
  • AVG Volume (30 Days)
  • KRYS 436.2K
  • CRC 905.0K
  • Earning Date
  • KRYS 05-06-2025
  • CRC 05-06-2025
  • Dividend Yield
  • KRYS N/A
  • CRC 3.51%
  • EPS Growth
  • KRYS 109.01
  • CRC 61.94
  • EPS
  • KRYS 4.16
  • CRC 5.76
  • Revenue
  • KRYS $333,448,000.00
  • CRC $3,312,000,000.00
  • Revenue This Year
  • KRYS $48.66
  • CRC $13.17
  • Revenue Next Year
  • KRYS $49.81
  • CRC N/A
  • P/E Ratio
  • KRYS $30.31
  • CRC $7.67
  • Revenue Growth
  • KRYS 247.53
  • CRC 43.01
  • 52 Week Low
  • KRYS $122.80
  • CRC $30.97
  • 52 Week High
  • KRYS $219.34
  • CRC $60.41
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 31.65
  • CRC 66.02
  • Support Level
  • KRYS $123.03
  • CRC $42.20
  • Resistance Level
  • KRYS $127.59
  • CRC $43.08
  • Average True Range (ATR)
  • KRYS 4.59
  • CRC 1.12
  • MACD
  • KRYS 0.39
  • CRC 0.13
  • Stochastic Oscillator
  • KRYS 18.15
  • CRC 94.14

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.

Share on Social Networks: